Related Experiment Videos
Adherence with statins over 8 years in a usual care setting
Shlomo Vinker1, Michal Shani, Tuvia Baevsky
1Department of Family Medicine, Tel Aviv University, POB 14238, Ashdod 77042, Israel. vinker01@zahav.net.il
The American Journal of Managed Care
|June 17, 2008
Summary
Statin adherence was poor in a large Israeli study, with new immigrants and younger/older patients showing lower rates. However, patients with chronic diseases exhibited better statin adherence.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Public Health
Background:
- Statin therapy is crucial for cardiovascular disease prevention.
- Understanding adherence patterns in real-world settings is essential for optimizing treatment outcomes.
- Determinants of statin adherence require investigation to inform targeted interventions.
Purpose of the Study:
- To evaluate statin treatment adherence within a routine healthcare system.
- To identify factors associated with improved statin adherence.
Main Methods:
- Retrospective cohort study utilizing administrative claims data.
- Analysis of 47,680 individuals prescribed statins between 1999-2006 in Israel.
- Inclusion of demographic, socioeconomic, and comorbidity data.
Main Results:
- Continuous adherence rates at 1, 3, and 6 years were 38.9%, 21.8%, and 9.6%, respectively.
- New immigrants and patients outside the 50-79 age range had significantly lower adherence.
- Patients with pre-existing or newly diagnosed chronic diseases demonstrated higher adherence.
Conclusions:
- Statin adherence in this population was suboptimal.
- Presence of chronic diseases positively influenced adherence.
- Targeted interventions are necessary, particularly for new immigrants and specific age groups.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...